semaglutide and sjogren's PDF) as a potential therapeutic adjunct for reducing flare-ups in Sjögren's syndrome: A case report A Pharmacological and Clinical Overview

Glucagon-like peptide 1 (GLP-1) is a hormone that enhances insulin secretion and shares similarities with glucagon

Micronutrient deficiencies in inflammatory bowel disease: from A to zinc

Within a few years, patients and clinicians will have a menu of options ranging from single-receptor oral pills to triple-receptor injectable agonists, each with distinct efficacy, safety, and convenience profiles

Obesity and diabetes both treated by GLP-1 drugs are also risk factors for Alzheimers and can cause changes in the brain that look similar to the disease

If medically urgent, your doctor can request expedited review, which is often processed within about 72 hours under federal rules for many plans